Google Cloud's updated its Vertex AI platform to support AI agents with including the Agent Development Kit, the Agent2Agent ...

As the U.S. stock market navigates a period of heightened volatility, with major indexes experiencing significant fluctuations amid tariff discussions and economic uncertainties, investors are keenly ...

Vertex Minerals (ASX:VTX) is progressing towards underground mining operations at its Reward Gold Mine. The company reports ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

Zacks Research has upped the financial bar for Vertex Pharmaceuticals, boosting its 2026 earnings forecast from $16.18 to $16 ...

BOSTON -- Patients with focal segmental glomerulosclerosis (FSGS) achieved some degree of proteinuria remission more often ...

Jefferies analyst Michael Yee maintained a Hold rating on Biogen (BIIB – Research Report) today and set a price target of $130.00. The ...

Despite a challenging 2024 for Boston’s life sciences market—marked by softening fundamentals and an oversupply of lab ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

While Accel is negotiating a deal with Vaya and August AI, Prosus is inching closer to a deal with Arivihan. Stellaris ...

J.P. Morgan analyst Jessica Fye maintained a Buy rating on Immunocore Holdings (IMCR – Research Report) on April 11 and set a price target of ...

One word takes up both clue and category in today's Connections puzzle, making the overall solution hard to find without some ...